FDA Inspection 1200239 — BlackSwan Vascular, Inc.
The FDA completed an inspection of BlackSwan Vascular, Inc. on March 13, 2023 in Hayward, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Hayward, CA (United States)
Additional Details
Sponsor, Contract Research Organization